Drug recall D-0541-2026
Product
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.
Reason for recall
Presence of particulate matter: a white thread-like structure in the cartridge
Lots and codes
Lots: a) WB00097, WB00094, WB00088, Expires: Jul. 2027; WB00103, Expires: Oct. 2027; WC00016, Expires: Dec. 2027; b) WB00098, WB00092, WB00093, Expires: Jul. 2027; WB00104, WB00106, WB00105, Expires: Oct. 2027.
Recall details
- Recalling firm
- Lupin Pharmaceuticals Inc., Naples, FL
- Quantity
- 217,621 pen injectors
- Distribution
- Nationwide within U.S
- Type
- Voluntary: Firm initiated
- Recall initiated
- April 24, 2026
Related products
- Liraglutide – drug information
- NDC 70748-346 Liraglutide · Liraglutide 6 mg/mL · Lupin Pharmaceuticals, Inc.